Colon Cancer in Young Adults: The Rise and the Red Flags

TL;DR: Colorectal cancer has been climbing in adults under 50 for decades, and the headlines about it are grounded in fact: it is now the leading cause of cancer death in men under 50 and the second in women under 50. The rise follows a birth-cohort pattern, where each successive generation carries higher risk than the one before at the same age, which points to something in modern early life rather than to aging. The honest counterpoint is that the increase is a large relative jump off a low base, so the chance that a given healthy young person without symptoms or family history has colorectal cancer remains small. Both of those are true, and holding them together is the whole point. The single most useful idea in this article is the line between screening and symptoms. Screening for average-risk adults now starts at 45, but screening is for people with no symptoms; a symptom deserves a workup at any age, and being under 45 is a reason you are not screened yet rather than a reason to wait. Rectal bleeding, a lasting change in bowel habits, iron-deficiency anemia, and unexplained weight loss are the red flags, and rectal bleeding above all raises the odds of colorectal cancer several-fold. The tragedy in young patients is diagnostic delay, when those symptoms get waved off as hemorrhoids, irritable bowel, or stress for months. The balanced response is awareness and prompt evaluation of symptoms rather than a colonoscopy for every worried thirty-year-old.

How much has colon cancer really risen in young adults?

The trend is unmistakable, and it has a distinctive shape. Since the mid-1980s, colon cancer has risen year over year in adults in their twenties and thirties, and rectal cancer has risen even faster in the youngest groups.¹ The clearest way to see it is by birth year: an adult born around 1990 carries roughly double the risk of colon cancer and about four times the risk of rectal cancer that an adult born around 1950 had at the same age.¹ That birth-cohort pattern, where each generation starts from a higher baseline, is the fingerprint of an early-life exposure rather than of getting older, and it is why researchers are looking at what changed in childhood diets and environments over the last half century.

The consequence has arrived faster than anyone predicted. By the most recent national cancer statistics, colorectal cancer has become the leading cause of cancer death in men under 50 and the second-leading cause, behind breast cancer, in women under 50, up from fourth place for both in the late 1990s.² That is a sobering change in a single generation.

Here is the part the scary headlines usually leave out, and it matters for keeping a level head. This is a steep relative rise off a low starting point. Colorectal cancer under 50 remains uncommon in absolute terms, on the order of a dozen or so cases per 100,000 people a year, and it still makes up only about a tenth of all colorectal cancer, which remains overwhelmingly a disease of people over 50. Risk also climbs sharply with age even inside the under-50 band, so a 47-year-old and a 30-year-old are not in the same tier. The honest reading is that the trend deserves attention and action, while the chance that any one healthy, symptom-free young adult has this cancer is still small.

Does this mean I need a colonoscopy now?

For most young adults, no, and understanding why is the most useful thing you can take from this. Screening, the routine testing of people who feel fine, now begins at age 45 for those at average risk, lowered from 50 because of the very rise described above.³ If you are 45 or older and have no symptoms, you are due. If you are younger than 45, at average risk, and have no symptoms, a colonoscopy is generally not recommended just because you read a frightening article.

The distinction that carries this whole topic is the one between screening and symptoms, and conflating the two is what harms young patients. Screening guidelines describe when a healthy person with no symptoms should start routine testing. They say nothing about a person who has a symptom. A thirty-year-old with rectal bleeding is not too young to be screened; they are not a screening candidate at all, they are a candidate for a diagnostic workup, and diagnostic evaluation has no lower age limit. Being under 45 means you are not yet in the routine screening window; it is never a reason to defer the evaluation of a red-flag symptom. That single idea, that a symptom is a different situation from screening, prevents the delay that turns a curable cancer into a dangerous one.

What symptoms should a young adult never ignore?

A handful of symptoms carry serious weight, and they are worth committing to memory because they are so easy to explain away. The strongest is rectal bleeding or blood in the stool, which in the research raises the odds of an early-onset colorectal cancer roughly fivefold.⁴ The other red flags are a persistent change in bowel habits, iron-deficiency anemia found on a blood test, ongoing abdominal pain, and unexplained weight loss. The risk stacks: having more than one of these together multiplies the odds further, so a young person with rectal bleeding and a changed bowel pattern and low iron is carrying a signal that should not be brushed aside.⁴

The reason this section matters more than any statistic is diagnostic delay. Young patients are often diagnosed months later than older ones, because their symptoms get attributed to hemorrhoids, irritable bowel syndrome, or stress, both by the patients themselves, who assume they are too young, and sometimes by clinicians. Those explanations are often correct, which is why they are dangerous: hemorrhoids are common and usually the cause of rectal bleeding, so the odds favor the benign answer, and that is what lets a cancer hide. The point is not that every symptom is cancer; it is that the benign explanation should be a conclusion reached after a proper look, rather than a first assumption that ends the conversation. If you have rectal bleeding, a bowel change that lasts more than a few weeks, or unexplained iron-deficiency anemia, ask directly whether you need a colonoscopy, and do not let your age be the reason it waits.

Why is early-onset colorectal cancer rising?

The most truthful answer is that no one knows the cause, and it is worth separating what is established from what is being investigated, because the space is full of confident claims that outrun the evidence. On the established side sit the familiar risk factors for colorectal cancer, several of which have tracked upward alongside the disease. Obesity is associated with a higher risk of early-onset colorectal cancer, roughly double in some studies of younger women.⁵ Sugar-sweetened beverages are another: heavy consumption of sugary drinks has been linked to about twice the risk, with intake during the teenage years appearing to matter.⁶ A Western dietary pattern low in fiber and high in processed and red meat, a sedentary life, alcohol, and smoking round out the list of established colorectal cancer risk factors, and they are the leading suspects behind the generational trend, though their specific contribution to the young-onset rise is not fully pinned down.

Then there are the active hypotheses, which are interesting and unproven, and should be labeled as such. The gut microbiome and early-life antibiotic use are plausible suspects under study. The most talked-about recent lead is colibactin, a DNA-damaging toxin made by certain strains of gut E. coli. A 2025 genomic study found that the mutational fingerprint colibactin leaves behind was several times more common in the tumors of people diagnosed before 40 than after 70, and appeared to be acquired in early childhood.⁷ That is a striking clue that fits the early-life-exposure picture, but it is a hypothesis-generating association from one study rather than a proven cause, and its own authors present it as a lead to chase rather than a verdict. The responsible summary is that diet, weight, and lifestyle are established levers, while the microbiome and colibactin are promising leads, and anyone claiming a single culprit for the rise is ahead of the science.

Does it run in families?

Family history and inherited genes account for a meaningful share of early-onset cases, which is why they deserve their own attention. In a landmark series, about one in six people diagnosed with colorectal cancer under 50 carried an inherited cancer-risk gene variant, with Lynch syndrome, the most common hereditary colorectal cancer condition, making up roughly half of those.⁸ Because that yield is so high, expert guidelines now recommend that everyone diagnosed with colorectal cancer under 50 be offered genetic testing.

For someone who has not been diagnosed but has relatives who were, family history is the clearest reason to start screening early. A first-degree relative, a parent, sibling, or child, with colorectal cancer raises your risk substantially and typically moves your starting age to 40, or to ten years before the age at which your youngest affected relative was diagnosed, whichever comes first, usually with colonoscopy rather than a stool test. A known syndrome like Lynch or familial polyposis calls for earlier and more frequent screening and formal genetic counseling. The practical step for every young adult is simple and often skipped: learn whether colorectal cancer or advanced polyps run in your family, and tell your physician, because it can change both when you start and how you screen.

What can you do about your risk?

The levers that lower colorectal cancer risk are the same unglamorous ones that improve most of health, and their honest description is that each helps modestly while together they add up over a lifetime. Staying physically active, keeping a healthy weight, eating more fiber and whole grains, limiting alcohol and processed and red meat, and not smoking all lower colorectal cancer risk. None is a guarantee, and the effect of any single change is moderate, but they line up with the leading hypotheses about the rise and they are worth doing on their own merits.

One item to cross off the list is aspirin. Older guidance once suggested low-dose aspirin partly to prevent colorectal cancer in some middle-aged adults, but the US Preventive Services Task Force removed colorectal cancer from its aspirin recommendation in 2022, concluding the evidence no longer supported it, and aspirin carries its own bleeding risk.⁹ So the plan for a young adult is not a pill. It is knowing your family history, starting screening at 45 if you are at average risk or earlier if your family history calls for it, living the modifiable levers, and, above all, treating red-flag symptoms as something to evaluate now rather than later.

Guidance from the Clinic

"The story I never want to hear again is the young patient who mentioned rectal bleeding for a year and was told, over and over, that it was hemorrhoids, until it turned out not to be. Most rectal bleeding is hemorrhoids, that part is true, but the benign answer has to be earned with a look, not assumed at the door. So when a patient under 45 tells me about bleeding, a bowel pattern that changed and stayed changed, low iron with no clear reason, or weight coming off without trying, I take it seriously and we work it up, and their age does not get a vote in whether we do that. At the same time, I spend just as much energy talking a frightened, symptom-free thirty-year-old down from demanding a colonoscopy they do not need, because the absolute risk at their age is still low. The two messages fit together: symptoms get evaluated at any age, and screening starts at 45 unless your family history moves it earlier. Know your family history, live the boring levers, and never let anyone wave off blood in the stool."

Related at Fishtown Medicine

• Colorectal Cancer Screening: Colonoscopy vs Cologuard vs FIT - how to screen once you are due, and how the tests compare
• Reading Your Family History - turning a family cancer history into an earlier-screening plan
• The Role of Genetic Testing - when Lynch syndrome and other inherited risks are worth testing for
• Ultra-Processed Food - one of the dietary levers tied to colorectal risk
• Alcohol and Longevity - where alcohol fits as a modifiable colorectal cancer risk

Scientific References

1. Siegel RL, Fedewa SA, Anderson WF, et al. "Colorectal Cancer Incidence Patterns in the United States, 1974-2013." Journal of the National Cancer Institute. 2017;109(8):djw322.
2. Siegel RL, Giaquinto AN, Jemal A. "Cancer Statistics, 2024." CA: A Cancer Journal for Clinicians. 2024;74(1):12-49.
3. US Preventive Services Task Force. "Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement." JAMA. 2021;325(19):1965-1977.
4. Fritz CDL, Otegbeye EE, Zong X, et al. "Red-Flag Signs and Symptoms for Earlier Diagnosis of Early-Onset Colorectal Cancer." Journal of the National Cancer Institute. 2023;115(8):909-916.
5. Liu PH, Wu K, Ng K, et al. "Association of Obesity with Risk of Early-Onset Colorectal Cancer Among Women." JAMA Oncology. 2019;5(1):37-44.
6. Hur J, Otegbeye E, Joh HK, et al. "Sugar-Sweetened Beverage Intake in Adulthood and Adolescence and Risk of Early-Onset Colorectal Cancer Among Women." Gut. 2021;70(12):2330-2336.
7. Diaz-Gay M, Dos Santos W, Moody S, et al. "Geographic and Age Variations in Mutational Processes in Colorectal Cancer." Nature. 2025;643(8071):230-240.
8. Pearlman R, Frankel WL, Swanson B, et al. "Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients with Early-Onset Colorectal Cancer." JAMA Oncology. 2017;3(4):464-471.
9. US Preventive Services Task Force. "Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement." JAMA. 2022;327(16):1577-1584.